Reliv' International (RELV) 10-Q 14 Nov 16 2016 Q3 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	9 Months Ended
	Sep. 30, 2016	Nov. 02, 2016
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2016
Document Fiscal Year Focus	2,016
Document Fiscal Period Focus	Q3
Entity Registrant Name	RELIV INTERNATIONAL INC
Entity Central Index Key	768,710
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Trading Symbol	RELV
Entity Common Stock, Shares Outstanding		1,845,587

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2016	Dec. 31, 2015
Current assets:
Cash and cash equivalents	$ 3,170,008	$ 3,262,263
Accounts receivable, less allowances of $29,300 in 2016 and $30,200 in 2015	6,562	89,376
Accounts and note due from employees and distributors	139,671	134,668
Inventories
Finished goods	2,675,895	3,657,612
Raw materials	1,398,963	1,382,635
Sales aids and promotional materials	146,523	132,475
Total inventories	4,221,381	5,172,722
Refundable income taxes	524,329	522,035
Prepaid expenses and other current assets	616,556	552,645
Deferred income taxes	0	66,000
Total current assets	8,678,507	9,799,709
Other assets	289,793	285,153
Cash surrender value of life insurance	2,935,963	2,848,232
Note receivable due from distributor	1,548,911	1,630,164
Deferred income taxes	500,000	623,000
Intangible assets, net	2,456,729	2,655,647
Property, plant and equipment:
Land and land improvements	905,190	905,190
Building	9,947,269	9,951,555
Machinery & equipment	4,329,392	4,344,403
Office equipment	1,205,690	1,223,921
Computer equipment & software	2,330,942	2,341,149
Property, plant, and equipment,Gross	18,718,483	18,766,218
Less: Accumulated depreciation	12,822,819	12,347,091
Net property, plant and equipment	5,895,664	6,419,127
Total assets	22,305,567	24,261,032
Accounts payable and accrued expenses:
Trade accounts payable and other accrued expenses	2,227,978	1,859,716
Distributors' commissions payable	1,448,035	1,567,883
Sales taxes payable	202,819	232,996
Payroll and payroll taxes payable	277,664	277,157
Total accounts payable and accrued expenses	4,156,496	3,937,752
Current portion of long-term debt	426,035	781,505
Total current liabilities	4,582,531	4,719,257
Noncurrent liabilities:
Long-term debt, less current portion	2,599,581	3,159,575
Deferred income taxes	0	94,000
Other noncurrent liabilities	382,340	405,705
Total noncurrent liabilities	2,981,921	3,659,280
Stockholders' equity:
Preferred stock, par value $.001 per share; 3,000,000 shares authorized; -0- shares issued and outstanding in 2016 and 2015	0	0
Common stock, par value $.001 per share; 30,000,000 authorized; 2,110,440 shares issued and 1,845,587 shares outstanding as of 9/30/2016; 2,110,440 shares issued and 1,845,587 shares outstanding as of 12/31/2015	14,773	14,773
Additional paid-in capital	30,551,899	30,499,817
Accumulated deficit	(9,556,608)	(8,659,262)
Accumulated other comprehensive loss:
Foreign currency translation adjustment	(930,389)	(634,273)
Treasury stock	(5,338,560)	(5,338,560)
Total stockholders' equity	14,741,115	15,882,495
Total liabilities and stockholders' equity	$ 22,305,567	$ 24,261,032

Condensed Consolidated Balance3

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)	Sep. 30, 2016	Dec. 31, 2015
Allowance for accounts receivable	$ 29,300	$ 30,200
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized	3,000,000	3,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized	30,000,000	30,000,000
Common stock, shares, issued	2,110,440	2,110,440
Common stock, shares, outstanding	1,845,587	1,845,587

Condensed Consolidated Statemen

Condensed Consolidated Statements of Net Income (Loss) and Comprehensive Income (Loss) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Product sales	$ 9,972,547	$ 11,250,271	$ 32,181,585	$ 36,401,384
Handling & freight income	812,868	944,182	2,693,602	3,072,783
Net sales	10,785,415	12,194,453	34,875,187	39,474,167
Costs and expenses:
Cost of products sold	2,214,633	2,603,167	7,729,508	8,245,871
Distributor royalties and commissions	3,799,791	4,308,647	12,345,171	14,048,971
Selling, general and administrative	4,737,305	5,659,989	15,887,901	18,244,930
Total costs and expenses	10,751,729	12,571,803	35,962,580	40,539,772
Income (loss) from operations	33,686	(377,350)	(1,087,393)	(1,065,605)
Other income (expense):
Interest income	26,199	28,536	80,689	88,991
Interest expense	(28,982)	(36,814)	(82,161)	(87,502)
Other income / (expense)	41,575	(72,373)	226,519	(227,434)
Income (loss) before income taxes	72,478	(458,001)	(862,346)	(1,291,550)
Provision (benefit) for income taxes	(62,000)	(169,000)	35,000	(273,000)
Net income (loss)	134,478	(289,001)	(897,346)	(1,018,550)
Other comprehensive income (loss):
Foreign currency translation adjustment	(74,503)	(72,673)	(296,116)	(23,734)
Comprehensive income (loss)	$ 59,975	$ (361,674)	$ (1,193,462)	$ (1,042,284)
Earnings (loss) per common share - Basic	$ 0.07	$ (0.16)	$ (0.49)	$ (0.55)
Weighted average shares	1,846,000	1,846,000	1,846,000	1,836,000
Earnings (loss) per common share - Diluted	$ 0.07	$ (0.16)	$ (0.49)	$ (0.55)
Weighted average shares	1,846,000	1,846,000	1,846,000	1,836,000

Condensed Consolidated Stateme5

Condensed Consolidated Statements of Cash Flows - USD ($)	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Operating activities:
Net loss	$ (897,346)	$ (1,018,550)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization	734,763	758,564
Stock-based compensation	52,083	45,981
Non-cash life insurance policy accretion	(87,732)	(75,216)
Deferred income taxes	27,000	(89,000)
Foreign currency transaction (gain)/loss	(191,091)	98,172
(Increase) decrease in accounts receivable and accounts due from employees and distributors	81,571	163,256
(Increase) decrease in inventories	868,287	(585,634)
(Increase) decrease in refundable income taxes	(2,153)	(214,378)
(Increase) decrease in prepaid expenses and other current assets	(71,431)	(123,423)
(Increase) decrease in other assets	(4,180)	23,247
Increase (decrease) in accounts payable & accrued expenses and other noncurrent liabilities	253,012	(86,860)
Net cash provided by (used in) operating activities	762,783	(1,103,841)
Investing activities:
Proceeds from the sale of property, plant and equipment	912	7,181
Purchase of property, plant and equipment	(18,686)	(224,719)
Payments received on distributor note receivable	76,534	72,088
Net cash provided by (used in) investing activities	58,760	(145,450)
Financing activities:
Repayment of line of credit borrowings	0	(500,000)
Proceeds from term loan borrowings	0	3,249,501
Principal payments on long-term borrowings	(904,461)	(3,334,552)
Net cash used in financing activities	(904,461)	(585,051)
Effect of exchange rate changes on cash and cash equivalents	(9,337)	3,915
Increase (decrease) in cash and cash equivalents	(92,255)	(1,830,427)
Cash and cash equivalents at beginning of period	3,262,263	4,989,392
Cash and cash equivalents at end of period	3,170,008	3,158,965
Noncash financing transactions (Note 5):
Issuance of promissory notes	0	424,000
Issuance of company common stock	$ 0	$ 117,000

Accounting Policies

Accounting Policies	9 Months Ended
	Sep. 30, 2016
Accounting Policies [Abstract]
Significant Accounting Policies [Text Block]	Note 1— Accounting Policies The accompanying unaudited condensed consolidated financial statements and notes thereto have been prepared in accordance with the instructions to Form 10-Q and reflect all adjustments (which primarily include normal recurring accruals) which management believes are necessary to present fairly the financial position, results of operations and cash flows. These statements, however, do not include all information and footnotes necessary for a complete presentation of financial position, results of operations and cash flows in conformity with accounting principles generally accepted in the United States. Interim results may not necessarily be indicative of results that may be expected for any other interim period or for the year as a whole. These financial statements should be read in conjunction with the audited consolidated financial statements and footnotes included in the annual report on Form 10-K for the year ended December 31, 2015, filed March 24, 2016 with the Securities and Exchange Commission. On October 4, 2016, the Company effected a 1-for-7 reverse stock split of the Company's common stock. Each stockholder's percentage ownership and proportional voting power remained unchanged as a result of the reverse stock split. All applicable share data, per share amounts, and related information in these Condensed Consolidated Financial Statements and notes thereto have been adjusted retroactively to give effect to the 1-for-7 reverse stock split.

Basic and Diluted Earnings (Los

Basic and Diluted Earnings (Loss) per Share	9 Months Ended
	Sep. 30, 2016
Earnings Per Share [Abstract]
Earnings Per Share [Text Block]	Note 2— Basic and Diluted Earnings (Loss) per Share Basic earnings (loss) per common share is computed using the weighted average number of common shares outstanding during the period. Diluted earnings (loss) per share is computed using the weighted average number of common shares and potential dilutive common shares that were outstanding during the period. Potential dilutive common shares consist of outstanding stock options, outstanding stock warrants, and convertible preferred stock. Three months ended September 30 Nine months ended September 30 2016 2015 2016 2015 Numerator: Net income (loss) $ 134,478 $ (289,001) $ (897,346) $ (1,018,550) Denominator: Denominator for basic earnings (loss) per share—weighted average shares 1,846,000 1,846,000 1,846,000 1,836,000 Dilutive effect of employee stock options and other warrants - - - - Denominator for diluted earnings (loss) per share—adjusted weighted average shares 1,846,000 1,846,000 1,846,000 1,836,000 Basic earnings (loss) per share $ 0.07 $ (0.16) $ (0.49) $ (0.55) Diluted earnings (loss) per share $ 0.07 $ (0.16) $ (0.49) $ (0.55) Options and warrants to purchase 265,001 267,184 270,958

Fair Value of Financial Instrum

Fair Value of Financial Instruments	9 Months Ended
	Sep. 30, 2016
Fair Value Disclosures [Abstract]
Fair Value Disclosures [Text Block]	Note 3— Fair Value of Financial Instruments Fair value can be measured using valuation techniques such as the market approach (comparable market prices), the income approach (present value of future income or cash flow), and the cost approach (cost to replace the service capacity of an asset or replacement cost). Accounting standards utilize a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those levels: Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets or similar assets or liabilities in markets that are not active. Level 3: Unobservable inputs that reflect the reporting entity's own assumptions. Description Carrying Value Fair Value Level 1 Level 2 Level 3 September 30, 2016 Long-term debt $ 3,025,616 $ 3,025,616 - $ 3,025,616 - Note receivable 1,656,449 1,900,000 - 1,900,000 - Marketable securities 264,000 264,000 $ 264,000 - - December 31, 2015 Long-term debt $ 3,941,080 $ 3,941,080 - $ 3,941,080 - Note receivable 1,732,982 1,942,000 - 1,942,000 - Marketable securities 275,000 275,000 $ 275,000 - - Long-term debt Note receivable Marketable securities The carrying value of other financial instruments, including cash, accounts receivable and accounts payable, and accrued liabilities approximate fair value due to their short maturities or variable-rate nature of their respective balances.

Taxes

Taxes	9 Months Ended
	Sep. 30, 2016
Income Tax Disclosure [Abstract]
Income Tax Disclosure [Text Block]	Note 4— Taxes Nine months ended September 30 2016 2015 Income taxes (benefit) at U.S. statutory rate $ (293,000) $ (439,000) State income taxes, net of federal benefit 20,000 36,000 Higher / (lower) effective taxes on earnings/losses in certain foreign countries (50,000) 39,000 Foreign corporate income taxes 66,000 32,000 Change in valuation allowance 363,000 - Other, net (71,000) 59,000 $ 35,000 $ (273,000) During the second quarter of 2016 (and affirmed in the third quarter of 2016), the Company determined that it was more likely than not that federal and various state net operating losses it expects to generate in 2016 will not be realized based on projections of future taxable income, estimated reversals of existing taxable timing differences, and other considerations. Accordingly, the income tax provision for the nine months ended September 30, 2016 includes the impact of recording a total valuation allowance of $ 363,000 One of the Company's foreign subsidiaries is presently under local country audit for alleged deficiencies (totaling approximately $ 800,000 20 185,000 156,000 142,000

Long-Term Incentive Compensatio

Long-Term Incentive Compensation Plan -- 2015	9 Months Ended
	Sep. 30, 2016
Compensation Related Costs [Abstract]
Compensation Related Costs, General [Text Block]	Note 5— Long-Term Incentive Compensation Plan — 2015 In July 2010, the Company’s Reliv Europe subsidiary entered into a long-term performance-based incentive compensation agreement with the subsidiary’s senior managers. The valuation of the compensation agreement was an EBITDA-based formula derived from the subsidiary’s financial performance and vested in 20 0 90,800 During the second quarter of 2015, the cumulative incentive amount of $ 756,800 100 424,000 100,000 117,000 216,000 The notes payable issued by the Company to the managers range in length from one to two years with quarterly payments of principal and interest beginning July 2015 and ending April 2017. The notes accrue interest at a floating interest rate based on the three-month pound LIBOR rate plus 3 101,000 3.49

Debt

Debt	9 Months Ended
	Sep. 30, 2016
Debt Disclosure [Abstract]
Long-term Debt [Text Block]	Note 6— Debt September 30 December 31 2016 2015 Term loan $ 2,924,541 $ 3,168,261 Notes payable 101,075 283,455 Obligation for acquisition of technology license, net - 489,364 3,025,616 3,941,080 Less current portion 426,035 781,505 Total long-term debt $ 2,599,581 $ 3,159,575 Twelve months ending September 30, 2017 $ 426,035 2018 2,599,581 $ 3,025,616 Term loan and revolving line agreements On September 30, 2015, the Company entered into a series of lending agreements with a new primary lender which include agreements for a $ 3.25 3.5 The $3.25 million term loan is for a period of three years and requires monthly 27,080 September 30, 2018 The term loan's interest rate is based on the 30-day LIBOR plus 2.25% 2.744 September 30, 2016 The $3.5 million revolving line of credit agreement, dated September 30, 2015, accrues interest at a floating interest rate based on the 30-day LIBOR plus 2.25% Borrowings under the lending agreements are secured by all tangible and intangible assets of the Company, a whole life insurance policy on the life of the Company’s Chief Executive Officer, and by a mortgage on the real estate of the Company’s headquarters. The original September 30, 2015 lending agreements include a quarterly covenant requiring the Company to maintain net tangible worth of not less than $9.5 million. 200,000 200,000 400,000 600,000 800,000 200,000 As defined, EBITDA means the Company's consolidated net income for such period, before interest expense, income tax expense, depreciation and amortization, and management fees, and further adjusted to exclude any gain or loss on the sale of assets, other extraordinary gains or losses, and any one-time adjustment approved by the lender. At September 30, 2016, the Company was in compliance with its loan covenant requirements. Obligation for Acquisition of Technology License, net In July 2013, the Company entered into a Technology License Agreement (TLA) with a privately-held company. The TLA provides the Company the exclusive license for certain intellectual property related to the nutritional ingredient lunasin and other soy-related peptins and proteins. In consideration for the TLA, the Company agreed to pay the licensor a purchase price of $ 2 1.15 150,000 250,000 250,000 250,000 Notes Payable A description of the notes payable is presented in Note 5 — Long-Term Incentive Compensation Plan.

Recent Accounting Standards Pen

Recent Accounting Standards Pending Adoption	9 Months Ended
	Sep. 30, 2016
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]
Recent Accounting Standards Pending Adoption [Text Block]	Note 7— Recent Accounting Standards Pending Adoption In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers In November 2015, the FASB issued ASU No. 2015-17, Income Taxes (Topic 740): Balance Sheet Classification of Deferred Taxes, In August 2014, the FASB issued ASU No. 2014-15, Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern In February 2016, the FASB issued ASU No. 2016-2, Leases (Topic 842) In March 2016, the FASB issued ASU No. 2016-09, Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting

Restructuring Activities

Restructuring Activities	9 Months Ended
	Sep. 30, 2016
Restructuring and Related Activities [Abstract]
Restructuring and Related Activities Disclosure [Text Block]	Note 8— Restructuring Activities In May 2016, the Company implemented an employee headcount cost reduction program resulting in the reduction of approximately 9 275,000 1,100,000 At September 30, 2016, there was no remaining reserve for severance and benefits under this program.

Accounting Policies (Policies)

Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2016
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]	Basis of Presentation The accompanying unaudited condensed consolidated financial statements and notes thereto have been prepared in accordance with the instructions to Form 10-Q and reflect all adjustments (which primarily include normal recurring accruals) which management believes are necessary to present fairly the financial position, results of operations and cash flows. These statements, however, do not include all information and footnotes necessary for a complete presentation of financial position, results of operations and cash flows in conformity with accounting principles generally accepted in the United States. Interim results may not necessarily be indicative of results that may be expected for any other interim period or for the year as a whole. These financial statements should be read in conjunction with the audited consolidated financial statements and footnotes included in the annual report on Form 10-K for the year ended December 31, 2015, filed March 24, 2016 with the Securities and Exchange Commission. On October 4, 2016, the Company effected a 1-for-7 reverse stock split of the Company's common stock. Each stockholder's percentage ownership and proportional voting power remained unchanged as a result of the reverse stock split. All applicable share data, per share amounts, and related information in these Condensed Consolidated Financial Statements and notes thereto have been adjusted retroactively to give effect to the 1-for-7 reverse stock split.

Basic and Diluted Earnings (L15

Basic and Diluted Earnings (Loss) per Share (Tables)	9 Months Ended
	Sep. 30, 2016
Earnings Per Share [Abstract]
Schedule of Calculation of Numerator and Denominator in Earnings Per Share [Table Text Block]	The following table sets forth the computation of basic and diluted earnings (loss) per share: Three months ended September 30 Nine months ended September 30 2016 2015 2016 2015 Numerator: Net income (loss) $ 134,478 $ (289,001) $ (897,346) $ (1,018,550) Denominator: Denominator for basic earnings (loss) per share—weighted average shares 1,846,000 1,846,000 1,846,000 1,836,000 Dilutive effect of employee stock options and other warrants - - - - Denominator for diluted earnings (loss) per share—adjusted weighted average shares 1,846,000 1,846,000 1,846,000 1,836,000 Basic earnings (loss) per share $ 0.07 $ (0.16) $ (0.49) $ (0.55) Diluted earnings (loss) per share $ 0.07 $ (0.16) $ (0.49) $ (0.55)

Fair Value of Financial Instr16

Fair Value of Financial Instruments (Tables)	9 Months Ended
	Sep. 30, 2016
Fair Value Disclosures [Abstract]
Fair Value, by Balance Sheet Grouping [Table Text Block]	The carrying amount and fair value of the Company's financial instruments are approximately as follows: Description Carrying Value Fair Value Level 1 Level 2 Level 3 September 30, 2016 Long-term debt $ 3,025,616 $ 3,025,616 - $ 3,025,616 - Note receivable 1,656,449 1,900,000 - 1,900,000 - Marketable securities 264,000 264,000 $ 264,000 - - December 31, 2015 Long-term debt $ 3,941,080 $ 3,941,080 - $ 3,941,080 - Note receivable 1,732,982 1,942,000 - 1,942,000 - Marketable securities 275,000 275,000 $ 275,000 - -

Taxes (Tables)

Taxes (Tables)	9 Months Ended
	Sep. 30, 2016
Income Tax Disclosure [Abstract]
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	The interim financial statement provision (benefit) for income taxes is different from the amounts computed by applying the United States federal statutory income tax rate of 34%. In summary, the reasons for these differences are as follows: Nine months ended September 30 2016 2015 Income taxes (benefit) at U.S. statutory rate $ (293,000) $ (439,000) State income taxes, net of federal benefit 20,000 36,000 Higher / (lower) effective taxes on earnings/losses in certain foreign countries (50,000) 39,000 Foreign corporate income taxes 66,000 32,000 Change in valuation allowance 363,000 - Other, net (71,000) 59,000 $ 35,000 $ (273,000)

Debt (Tables)

Debt (Tables)	9 Months Ended
	Sep. 30, 2016
Debt Disclosure [Abstract]
Schedule of Long-term Debt Instruments [Table Text Block]	September 30 December 31 2016 2015 Term loan $ 2,924,541 $ 3,168,261 Notes payable 101,075 283,455 Obligation for acquisition of technology license, net - 489,364 3,025,616 3,941,080 Less current portion 426,035 781,505 Total long-term debt $ 2,599,581 $ 3,159,575
Schedule of Maturities of Long-term Debt [Table Text Block]	Estimated maturities of debt at September 30, 2016 are as follows: Twelve months ending September 30, 2017 $ 426,035 2018 2,599,581 $ 3,025,616

Accounting Policies (Details Te

Accounting Policies (Details Textual)	Oct. 04, 2016
Subsequent Event [Member]
Stockholders' Equity, Reverse Stock Split	1-for-7

Basic and Diluted Earnings (L20

Basic and Diluted Earnings (Loss) per Share (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Numerator:
Net income (loss)	$ 134,478	$ (289,001)	$ (897,346)	$ (1,018,550)
Denominator:
Denominator for basic earnings (loss) per share—weighted average shares	1,846,000	1,846,000	1,846,000	1,836,000
Dilutive effect of employee stock options and other warrants	0	0	0	0
Denominator for diluted earnings (loss) per share—adjusted weighted average shares	1,846,000	1,846,000	1,846,000	1,836,000
Basic earnings (loss) per share	$ 0.07	$ (0.16)	$ (0.49)	$ (0.55)
Diluted earnings (loss) per share	$ 0.07	$ (0.16)	$ (0.49)	$ (0.55)

Basic and Diluted Earnings (L21

Basic and Diluted Earnings (Loss) per Share (Details Textual) - shares	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	265,001	270,958	267,184	270,958

Fair Value of Financial Instr22

Fair Value of Financial Instruments (Details) - USD ($)	Sep. 30, 2016	Dec. 31, 2015
Fair Value of Financial Instruments [Line Items]
Long-term debt, Carrying Amount	$ 3,025,616	$ 3,941,080
Note receivable, Carrying Amount	1,656,449	1,732,982
Marketable securities, Carrying Amount	264,000	275,000
Long-term debt, Fair Value	3,025,616	3,941,080
Note receivable, Fair Value	1,900,000	1,942,000
Marketable securities, Fair Value	264,000	275,000
Fair Value, Inputs, Level 1 [Member]
Fair Value of Financial Instruments [Line Items]
Long-term debt, Fair Value	0	0
Note receivable, Fair Value	0	0
Marketable securities, Fair Value	264,000	275,000
Fair Value, Inputs, Level 2 [Member]
Fair Value of Financial Instruments [Line Items]
Long-term debt, Fair Value	3,025,616	3,941,080
Note receivable, Fair Value	1,900,000	1,942,000
Marketable securities, Fair Value	0	0
Fair Value, Inputs, Level 3 [Member]
Fair Value of Financial Instruments [Line Items]
Long-term debt, Fair Value	0	0
Note receivable, Fair Value	0	0
Marketable securities, Fair Value	$ 0	$ 0

Taxes (Details)

Taxes (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Provision Benefit For Income Taxes [Line Items]
Income taxes (benefit) at U.S. statutory rate			$ (293,000)	$ (439,000)
State income taxes, net of federal benefit			20,000	36,000
Higher / (lower) effective taxes on earnings/losses in certain foreign countries			(50,000)	39,000
Foreign corporate income taxes			66,000	32,000
Change in valuation allowance			363,000	0
Other, net			(71,000)	59,000
Income Tax Expense (Benefit), Total	$ (62,000)	$ (169,000)	$ 35,000	$ (273,000)

Taxes (Details Textual)

Taxes (Details Textual) - USD ($)	1 Months Ended	9 Months Ended	36 Months Ended
	Dec. 31, 2010	Sep. 30, 2016	Dec. 31, 2006	Dec. 31, 2015
Income Taxes [Line Items]
Vat And Withholding Taxes			$ 800,000
Interest Penalty Percentage			20.00%
Selling, General and Administrative Expense	$ 185,000
Management Estimated Reserve For Tax		$ 156,000		$ 142,000
Valuation Allowance Deferred Tax Assets For Net Operating Losses Domestic		$ 363,000

Long-Term Incentive Compensat25

Long-Term Incentive Compensation Plan -- 2015 (Details Textual) - USD ($)	1 Months Ended			3 Months Ended			9 Months Ended		60 Months Ended
	Jul. 31, 2015	Apr. 30, 2015	Apr. 30, 2011	Sep. 30, 2016	Sep. 30, 2015	Jun. 30, 2015	Sep. 30, 2016	Sep. 30, 2015	Jun. 30, 2015	Dec. 31, 2015
Long-Term Incentive Compensation Plan [Line Items]
Performance Based Incentive Compensation Vest Based On Annual Increment Percentage			20.00%
Notes Payable, Total				$ 101,075			$ 101,075			$ 283,455
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage						100.00%
Other Selling, General and Administrative Expense				$ 4,737,305	$ 5,659,989		$ 15,887,901	$ 18,244,930
Incentive Compensation Plan [Member]
Long-Term Incentive Compensation Plan [Line Items]
Deferred Compensation Arrangement with Individual, Compensation Expense									$ 756,800
Deferred Compensation Arrangement With Individual Shares To Be Issued	100,000
Deferred Compensation Arrangement With Individual Fair Value Of Shares To Be Issued	$ 117,000
Debt Instrument, Interest Rate, Stated Percentage				3.49%			3.49%
Deferred Compensation Arrangement With Individual Distributions Payments	$ 216,000
Other Selling, General and Administrative Expense					$ 0			$ 90,800
Incentive Compensation Plan [Member] | London Interbank Offered Rate (LIBOR) [Member]
Long-Term Incentive Compensation Plan [Line Items]
Debt Instrument, Basis Spread on Variable Rate							3.00%
Incentive Compensation Plan [Member] | Notes Payable, Other Payables [Member]
Long-Term Incentive Compensation Plan [Line Items]
Deferred Compensation Arrangement With Individual Distributions Payments		$ 424,000

Debt (Details)

Debt (Details) - USD ($)	Sep. 30, 2016	Dec. 31, 2015
Carrying Value Of Debt [Line Items]
Term loan	$ 2,924,541	$ 3,168,261
Notes payable	101,075	283,455
Obligation for acquisition of technology license, net	0	489,364
Long-term Debt	3,025,616	3,941,080
Less current portion	426,035	781,505
Total long-term debt	$ 2,599,581	$ 3,159,575

Debt (Details 1)

Debt (Details 1) - USD ($)	Sep. 30, 2016	Dec. 31, 2015
Long-term Debt, Rolling Maturity [Line Items]
2,017	$ 426,035
2,018	2,599,581
Long-term Debt	$ 3,025,616	$ 3,941,080

Debt (Details Textual)

Debt (Details Textual) - USD ($)	1 Months Ended	3 Months Ended	9 Months Ended
	Jul. 31, 2013	Sep. 30, 2016	Sep. 30, 2016	Dec. 31, 2015	Sep. 30, 2015
Carrying Value Of Debt [Line Items]
Secured Debt		$ 2,924,541	$ 2,924,541	$ 3,168,261
December 31, 2016 [Member]
Carrying Value Of Debt [Line Items]
Debt Instrument, Restrictive Covenants, Expected Minimum Earnings Before Interest Expense, Income Tax Expense, Depreciation, And Amortization			200,000
March 31, 2017 [Member]
Carrying Value Of Debt [Line Items]
Debt Instrument, Restrictive Covenants, Expected Minimum Earnings Before Interest Expense, Income Tax Expense, Depreciation, And Amortization			200,000
June 30, 2017 [Member]
Carrying Value Of Debt [Line Items]
Debt Instrument, Restrictive Covenants, Expected Minimum Earnings Before Interest Expense, Income Tax Expense, Depreciation, And Amortization			400,000
September 30, 2017 [Member]
Carrying Value Of Debt [Line Items]
Debt Instrument, Restrictive Covenants, Expected Minimum Earnings Before Interest Expense, Income Tax Expense, Depreciation, And Amortization			600,000
December 31, 2017 [Member]
Carrying Value Of Debt [Line Items]
Debt Instrument, Restrictive Covenants, Expected Minimum Earnings Before Interest Expense, Income Tax Expense, Depreciation, And Amortization			800,000
March 31, 2018 [Member]
Carrying Value Of Debt [Line Items]
Debt Instrument, Restrictive Covenants, Expected Minimum Earnings Before Interest Expense, Income Tax Expense, Depreciation, And Amortization			200,000
Technology License [Member]
Carrying Value Of Debt [Line Items]
Payments to Acquire Intangible Assets	$ 1,150,000
Technology License Agreement Periodic Payment Range Minimum Amount	150,000
Technology License Agreement Periodic Payment Range Maximum Amount	250,000
Finite-lived Intangible Assets Acquired	$ 2,000,000
Final Payment Made For License			$ 250,000
Technology License [Member] | Intellectual Property [Member]
Carrying Value Of Debt [Line Items]
Payments to Acquire Intangible Assets		$ 250,000
Finite-Lived Intangible Asset, Useful Life		17 years
Revolving Credit Facility [Member]
Carrying Value Of Debt [Line Items]
Debt Instrument, Maturity Date			Sep. 30, 2016
Line of Credit Facility, Maximum Borrowing Capacity					$ 3,500,000
Line of Credit Facility, Interest Rate Description			a floating interest rate based on the 30-day LIBOR plus 2.25%
Term Loan [Member]
Carrying Value Of Debt [Line Items]
Secured Debt					$ 3,250,000
Secured Debt [Member]
Carrying Value Of Debt [Line Items]
Debt Instrument, Description Of Variable Rate Basis			The term loan's interest rate is based on the 30-day LIBOR plus 2.25%
Debt Instrument, Frequency Of Periodic Payment			monthly
Debt Instrument, Periodic Payment, Principal			$ 27,080
Debt Instrument, Maturity Date			Sep. 30, 2018
Debt Instrument, Term			3 years
Debt Instrument, Restrictive Covenants			The original September 30, 2015 lending agreements include a quarterly covenant requiring the Company to maintain net tangible worth of not less than $9.5 million.
Debt Instrument, Interest Rate, Stated Percentage		2.744%	2.744%
Debt Instrument, Amortization Period			10 years

Restructuring Activities (Detai

Restructuring Activities (Details Textual) - USD ($)	1 Months Ended	3 Months Ended
	May 31, 2016	Jun. 30, 2016
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Number of Positions Eliminated, Period Percent	9.00%
Severance Costs		$ 275,000
Labor and Related Expense	$ 1,100,000